CN115060913A - A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit - Google Patents
A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit Download PDFInfo
- Publication number
- CN115060913A CN115060913A CN202210817114.XA CN202210817114A CN115060913A CN 115060913 A CN115060913 A CN 115060913A CN 202210817114 A CN202210817114 A CN 202210817114A CN 115060913 A CN115060913 A CN 115060913A
- Authority
- CN
- China
- Prior art keywords
- protein chip
- antigen
- interleukin
- antibody
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5406—IL-4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5409—IL-5
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5412—IL-6
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5421—IL-8
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5428—IL-10
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5437—IL-13
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/55—IL-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
- G01N2333/57—IFN-gamma
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本申请涉及生物检测技术的领域,尤其是涉及一种用于定量检测多种细胞因子的蛋白芯片及其制备方法以及试剂盒。用于定量检测多种细胞因子的蛋白芯片,包括基片以及至少一种抗原特异性抗体,所述抗原特异性抗体固定于基片形成抗体微阵列。用于定量检测多种细胞因子的试剂盒,包括蛋白芯片、适配器、细胞因子标准品以及荧光染料标记的检测抗体。本申请具有灵敏度高,特异性强,准确高效,适用于多种场景的效果。The present application relates to the field of biological detection technology, in particular to a protein chip for quantitative detection of various cytokines, a preparation method and a kit thereof. A protein chip for quantitatively detecting multiple cytokines includes a substrate and at least one antigen-specific antibody, and the antigen-specific antibody is immobilized on the substrate to form an antibody microarray. Kits for quantitative detection of multiple cytokines, including protein chips, adapters, cytokine standards, and fluorescent dye-labeled detection antibodies. The present application has the effects of high sensitivity, strong specificity, accuracy and efficiency, and is suitable for various scenarios.
Description
技术领域technical field
本申请涉及生物检测技术的领域,尤其是涉及一种用于定量检测多种细胞因子的蛋白芯片及其制备方法以及试剂盒。The present application relates to the field of biological detection technology, in particular to a protein chip for quantitative detection of various cytokines, a preparation method and a kit thereof.
背景技术Background technique
细胞因子(cytokine)是主要由免疫细胞所合成和分泌的小分子多肽或糖蛋白,主要包括白介素、干扰素、肿瘤坏死因子、生长因子、趋化因子等。众多细胞因子在体内通过旁分泌、自分泌或内分泌等方式分泌,具有多效性、重叠性、拮抗性、协同性的特性,形成了十分复杂的细胞因子调节网络,同时也参与人体多种重要的生理功能,如介导细胞间相作,调节细胞生长、分化成熟、功能维持、调节免疫应答、参与炎症反应、创伤愈合和肿瘤消长等功能,因此细胞因子的定量检测对于疾病诊断十分必要。Cytokines are small-molecule polypeptides or glycoproteins mainly synthesized and secreted by immune cells, including interleukins, interferons, tumor necrosis factors, growth factors, and chemokines. Numerous cytokines are secreted in the body by paracrine, autocrine or endocrine, and have the characteristics of pleiotropic, overlapping, antagonistic, and synergistic, forming a very complex cytokine regulatory network, and are also involved in many important human body. The physiological functions of cytokines, such as mediating intercellular interactions, regulating cell growth, differentiation and maturation, function maintenance, regulating immune response, participating in inflammatory response, wound healing, and tumor growth and decline, etc., so the quantitative detection of cytokines is very necessary for disease diagnosis.
传统的细胞因子定量检测方法主要有:酶联免疫法(ELISA),放射免疫分析(radioimmunoassay,RIA),免疫印迹法(western blot),液相磁珠法(LUMINEX)等。其中,酶联免疫法最为普遍,其灵敏度高、特异性较好。但其实验步骤复杂且通量低,由于受限于酶标板的底面积,所以包被抗体或抗原量大,因而成本高,在多重细胞因子检测中,该方法不能快速检测;放射免疫分析(RIA)灵敏度高,但具有放射性污染,对实验操作者的健康存在潜在威胁;免疫印迹法操作繁琐,周期长,检测指标单一,且对操作者的实验技能要求高,同样也不适用于多重细胞因子检测。而液相磁珠法是通过把抗原特异性抗体固定在有不同荧光波长的磁珠上,所有磁珠在同一液相完成反应后流经检测处记录荧光读数。读不同的磁珠信号用以代表检测物,另一个荧光信号代表磁珠上的浓度。因为固定有不同抗原特异性抗体的磁珠在同一反应体系中进行,抗原特异性抗体彼此之间就有交叉干扰,以至于检测结果的重复性差,且成本高。The traditional quantitative detection methods of cytokines mainly include: enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), western blot, liquid magnetic beads method (LUMINEX) and so on. Among them, enzyme-linked immunosorbent assay is the most common, with high sensitivity and specificity. However, the experimental steps are complex and the throughput is low. Due to the limitation of the bottom area of the ELISA plate, the amount of coated antibody or antigen is large, so the cost is high. In multiple cytokine detection, this method cannot be used for rapid detection; radioimmunoassay (RIA) has high sensitivity, but has radioactive contamination, which poses a potential threat to the health of the experimental operator; the immunoblotting method is cumbersome to operate, has a long cycle, a single detection index, and requires high experimental skills of the operator, and is also not suitable for multiplex Cytokine detection. In the liquid-phase magnetic bead method, antigen-specific antibodies are immobilized on magnetic beads with different fluorescent wavelengths. A different bead signal is read to represent the test substance, and another fluorescent signal represents the concentration on the bead. Because the magnetic beads immobilized with different antigen-specific antibodies are carried out in the same reaction system, the antigen-specific antibodies have cross-interference with each other, so that the reproducibility of the detection results is poor and the cost is high.
因此,开发一种快速、灵敏、简单便捷的多重细胞因子检测试剂盒非常必要。Therefore, it is necessary to develop a rapid, sensitive, simple and convenient multiplex cytokine detection kit.
发明内容SUMMARY OF THE INVENTION
为了解决现有的检测方法成本高,检测周期长的问题,本申请提供一种定量检测多种细胞因子的蛋白芯片试剂盒,其灵敏度高,特异性强,准确高效,适用于多种场景。In order to solve the problems of high cost and long detection period of the existing detection methods, the present application provides a protein chip kit for quantitative detection of various cytokines, which has high sensitivity, strong specificity, accuracy and efficiency, and is suitable for various scenarios.
第一方面,本申请提供的一种定量检测多种细胞因子的蛋白芯片试剂盒,采用如下的技术方案:In the first aspect, a protein chip kit for quantitatively detecting multiple cytokines provided by this application adopts the following technical scheme:
一种用于定量检测多种细胞因子的蛋白芯片,包括基片以及至少一种抗原特异性抗体,所述抗原特异性抗体固定于基片形成多个互相分离的抗体微阵列。A protein chip for quantitatively detecting multiple cytokines comprises a substrate and at least one antigen-specific antibody, the antigen-specific antibody is immobilized on the substrate to form a plurality of mutually separated antibody microarrays.
通过采用上述技术方案,不同的抗原特异性抗体相互分离固定在基片表面,因此可减少不同抗原特异性抗体彼此干扰,即减少样品间交叉污染的可能性,具有细胞因子高通量检测的可行性。By adopting the above technical solution, different antigen-specific antibodies are separated from each other and fixed on the surface of the substrate, so the interference of different antigen-specific antibodies with each other can be reduced, that is, the possibility of cross-contamination between samples is reduced, and high-throughput detection of cytokines is feasible. sex.
同时,减少不同微阵列点检的荧光信号的相互干扰,因此一次可同时检测多种细胞因子,且检测细胞因子的灵敏度可达到单因子的ELISA检测的灵敏度。At the same time, the mutual interference of fluorescent signals of different microarray inspections is reduced, so multiple cytokines can be simultaneously detected at one time, and the sensitivity of detecting cytokines can reach the sensitivity of single-factor ELISA detection.
可选的,针对每种待检测物的抗原特异性抗体在微阵列中有至少三次重复。Optionally, the antigen-specific antibodies to each analyte are replicated at least three times in the microarray.
通过采用上述技术方案,待检测抗原至少三次重复,那么至少可以从单一样本中获得至少三倍于ELISA的实验结果。By adopting the above technical solution, the antigen to be detected is repeated at least three times, then at least three times the experimental result of ELISA can be obtained from a single sample.
可选的,所述基片为PS,PC,PVC,PMMA或其他同类型材料。Optionally, the substrate is PS, PC, PVC, PMMA or other materials of the same type.
可选的,多种所述抗原特异性抗体为干扰素γ、白介素-1、白介素-2、白介素4、白介素5、白介素6、白介素8、白介素10、白介素13和肿瘤坏死因子α的特异性抗体中的一种或几种的组合。Optionally, a plurality of the antigen-specific antibodies are specific for interferon gamma, interleukin-1, interleukin-2, interleukin-4, interleukin-5, interleukin-6, interleukin-8, interleukin-10, interleukin-13 and tumor necrosis factor-alpha. One or a combination of antibodies.
可选的,多种抗原特异性抗体的包被浓度可以100-500μg/ml。Optionally, the coating concentration of various antigen-specific antibodies can be 100-500 μg/ml.
第二方面,本申请提供的一种上述蛋白芯片的制备方法,采用如下的技术方案:In the second aspect, the preparation method of the above-mentioned protein chip provided by this application adopts the following technical scheme:
一种上述蛋白芯片的制备方法,包括以下步骤:A preparation method of the above protein chip, comprising the following steps:
S1、取基片进行修饰,得到修饰基片;S1, take the substrate and modify it to obtain a modified substrate;
S2、将100-1000pl特异性抗体蛋白质的PBS缓冲液点样于所述修饰基片上,将点好样的修饰基片于20-37℃孵育1-2小时或2-8℃湿盒孵育过夜后封闭,2-8℃保存备用。S2. Spot 100-1000pl of PBS buffer of specific antibody protein on the modified substrate, and incubate the spotted modified substrate at 20-37°C for 1-2 hours or in a wet box at 2-8°C overnight After sealing, store at 2-8°C for later use.
可选的,基片的修饰方式可以是随机吸附、EDC、EDC-NHS、活性醛基、活性羧基、活性氨基、多巴胺包被、受体-配体法中的一种或几种组合。Optionally, the modification of the substrate can be one or a combination of random adsorption, EDC, EDC-NHS, active aldehyde group, active carboxyl group, active amino group, dopamine coating, and receptor-ligand method.
可选的,每个抗原特异性抗体在每个抗体微阵列中至少有三次重复,其点样方式可以是在一个芯片上仅点一种或几种不同抗原特异性抗体的组合。Optionally, each antigen-specific antibody is repeated at least three times in each antibody microarray, and the spotting manner may be to spot only one or a combination of several different antigen-specific antibodies on one chip.
可选的,采用3%-10%的脱脂奶粉,5%的BSA或乙醇胺16-37℃孵育1-2小时后,清洗封闭。Optionally, use 3%-10% nonfat dry milk, 5% BSA or ethanolamine to incubate for 1-2 hours at 16-37°C, then wash and block.
第三方面,本申请提供的一种用于定量检测多种细胞因子的试剂盒,采用如下的技术方案:In the third aspect, a kit for quantitatively detecting multiple cytokines provided by the application adopts the following technical scheme:
一种用于定量检测多种细胞因子的试剂盒,包括上述蛋白芯片、适配器、细胞因子标准品以及荧光染料标记的检测抗体。A kit for quantitatively detecting multiple cytokines, comprising the above-mentioned protein chip, an adapter, a cytokine standard and a detection antibody labeled with a fluorescent dye.
检测抗体可以按照实验要求混合一种或多种有荧光染料标记的抗原特异性检测抗体,荧光染料可以为:Cy3,Cy5,FITC等具有类似吸收波长的荧光染料;标准品,包含一种或若干种所述的细胞因子的具有梯级浓度的混合物。The detection antibody can be mixed with one or more antigen-specific detection antibodies labeled with fluorescent dyes according to the experimental requirements. The fluorescent dyes can be: Cy3, Cy5, FITC and other fluorescent dyes with similar absorption wavelengths; the standard contains one or several Mixtures with graded concentrations of the cytokines.
可选的,所述适配器是抗体微阵嵌套分割的适配器框架,其每个小区域含有一个抗体微阵列。Optionally, the adapter is an antibody microarray nested segmented adapter framework, each of which contains one antibody microarray.
综上所述,本申请包括以下至少一种有益技术效果:To sum up, the present application includes at least one of the following beneficial technical effects:
1.不同的抗原特异性抗体相互分离固定在基片表面,因此可减少不同抗原特异性抗体彼此干扰,即减少样品间交叉污染的可能性,又具有细胞因子高通量检测的可行性。1. Different antigen-specific antibodies are separated from each other and fixed on the surface of the substrate, so it can reduce the interference of different antigen-specific antibodies, which reduces the possibility of cross-contamination between samples, and has the feasibility of high-throughput detection of cytokines.
2.试剂盒配套可将抗体微阵嵌套分割的适配器框架,其每个小区域含有一个抗体微阵列,每个小区含有一个抗体微阵列。这样,在同一张玻片上可同时检测多个不同的样品。多个可拆装的框架的尺寸大小与常规孔板大小适配,可以直接用于对应孔板样品监测。与常规ELISA相比,该反应体系为在玻片表面上进行的多个样品的多重ELISA检测。2. The kit is equipped with an adapter frame that can nest and divide antibody microarrays. Each small area contains an antibody microarray, and each small area contains an antibody microarray. In this way, multiple different samples can be tested simultaneously on the same slide. The dimensions of the multiple detachable frames are adapted to the size of the conventional orifice plate, and can be directly used for sample monitoring of the corresponding orifice plate. In contrast to conventional ELISA, the reaction system is a multiplex ELISA detection of multiple samples on the surface of a glass slide.
3.为确保蛋白芯片操作简便、样品间不交叉污染,成高通量方法,各特异性抗体蛋白质芯片点阵排布于塑料蛋白芯片,抗体的排布可以根据不用实验需求进行调整和改进,蛋白芯片反应完成后,可直接将基片进行镭射扫描仪扫描,可以采用博奥晶典(CapitalBioTechnology)公司生产的芯片扫描仪或者NanoEntek公司的Juli Stage扫描拼接显微镜进行扫描,然后通过数码处理软件把荧光信号转化为具体数字,再通过软件换算出细胞因子的浓度。3. In order to ensure that the protein chip is easy to operate, does not cross-contaminate between samples, and is a high-throughput method, each specific antibody protein chip array is arranged on a plastic protein chip, and the arrangement of antibodies can be adjusted and improved according to different experimental needs. After the protein chip reaction is completed, the substrate can be directly scanned by a laser scanner, which can be scanned by the chip scanner produced by CapitalBioTechnology or the Juli Stage scanning splicing microscope produced by NanoEntek, and then scanned by digital processing software. The fluorescent signal was converted into a specific number, and then the concentration of cytokines was converted by software.
附图说明Description of drawings
图1是本申请适配器的整体结构示意图;1 is a schematic diagram of the overall structure of the adapter of the present application;
图2是本申请适配器的爆炸示意图;Fig. 2 is the exploded schematic diagram of the adapter of the present application;
图3是本申请适配器的俯视图;Fig. 3 is the top view of the adapter of the present application;
图4是图3中A-A的剖视图;Fig. 4 is the sectional view of A-A in Fig. 3;
图5是本申请适配器与孔板或inserts联用的示意图;Figure 5 is the application adapter with orifice plate or Schematic diagram of the combination of inserts;
图6是实施例2定量检测白介素6的标准曲线;Fig. 6 is the standard curve that
图7是实施例2在不同使用场景下定量检测白介素6以及与ELISA对比的结果示意图;7 is a schematic diagram of the results of quantitative detection of interleukin-6 and comparison with ELISA in Example 2 under different usage scenarios;
图8是实施例3定量检测多种细胞因子的标准曲线。FIG. 8 is the standard curve of quantitative detection of various cytokines in Example 3. FIG.
附图标记说明:1、外框;2、内框;3、软乳胶片;4、安装孔;5、定位环;6、阶梯台;7、定位块;8、蛋白芯片;9、样品标号区。Description of reference numerals: 1, outer frame; 2, inner frame; 3, soft latex sheet; 4, mounting hole; 5, positioning ring; 6, step table; 7, positioning block; 8, protein chip; 9, sample label Area.
具体实施方式Detailed ways
实施例1:以白介素6为例的蛋白芯片的制备Example 1: Preparation of protein chip using interleukin-6 as an example
以白介素6为例的蛋白芯片的制备方法如下:The preparation method of a protein chip using interleukin-6 as an example is as follows:
(1)蛋白芯片8的基片可为PS,PC,PVC,PMMA或其他同类型材料。本申请实施例1基片材料为PMMA。另外,基片的修饰方式可以是随机吸附、EDC、EDC-NHS、活性醛基、活性羧基、活性氨基、多巴胺包被、受体-配体法中的一种或几种组合。本申请实施例1采用随机吸附。(1) The substrate of the
(2)在修饰后的PMMA基片上进行抗白介素6抗体的(DA012,近岸蛋白质科技有限公司)点样。其中,多种抗原特异性抗体的包被浓度为500μg/ml,将1000pl含有特异性抗体蛋白质的PBS缓冲液(含10%甘油)点样于基片上,每个抗原特异性抗体在每个抗体微阵列中有三次重复,其点样方式可以是在一个芯片上仅点一种或几种不同抗原特异性抗体的组合。共在16个可以适配96孔板大小的芯片上进行点样,将点好样的芯片于37℃孵育2小时,2℃保存备用或封闭。(2) Spotting of anti-interleukin-6 antibody (DA012, Nearshore Protein Technology Co., Ltd.) was performed on the modified PMMA substrate. Among them, the coating concentration of various antigen-specific antibodies was 500 μg/ml, and 1000pl of PBS buffer (containing 10% glycerol) containing specific antibody proteins was spotted on the substrate, and each antigen-specific antibody was placed on each antibody. There are three replicates in the microarray, and the spotting method can be to spot only one or a combination of several different antigen-specific antibodies on a chip. A total of 16 chips that can fit into a 96-well plate were spotted, and the chips that had been spotted were incubated at 37°C for 2 hours, and stored at 2°C for later use or blocked.
需要说明的是,多种抗原特异性抗体的包被浓度以及含量可以不同,在一些实施例中,多种抗原特异性抗体的包被浓度为100-500μg/ml,将含有100-1000pl特异性抗体蛋白质的PBS缓冲液(含有10%-50%的甘油)点样于基片上。It should be noted that the coating concentration and content of multiple antigen-specific antibodies can be different. In some embodiments, the coating concentration of multiple antigen-specific antibodies is 100-500 μg/ml, which will contain 100-1000pl specificity Antibody protein in PBS buffer (containing 10%-50% glycerol) was spotted on the substrate.
孵育温度也可以是20-37℃,孵育时间1-2小时,或,2-8℃湿盒孵育过夜;保存温度也可以是2-8℃。The incubation temperature can also be 20-37°C, the incubation time is 1-2 hours, or the incubation temperature can be 2-8°C overnight in a humid box; the storage temperature can also be 2-8°C.
具体的,封闭过程为:5%的脱脂奶粉37℃孵育2小时,用PBS缓冲液(含有10%的甘油)清洗3次,每次5min,其中,静置2min,摇动3min。Specifically, the blocking process was as follows: incubate with 5% nonfat dry milk at 37° C. for 2 hours, wash with PBS buffer (containing 10% glycerol) for 3 times for 5 minutes each time, in which, stand for 2 minutes and shake for 3 minutes.
当然,在另一实施例中,可以是3%-10%的脱脂奶粉,也可以是5%BSA或乙醇胺,16-37℃孵育1-2小时后用PBS缓冲液(含有10%-50%的甘油)清洗。Of course, in another embodiment, it can be 3%-10% skimmed milk powder, or 5% BSA or ethanolamine, incubated at 16-37°C for 1-2 hours and then treated with PBS buffer (containing 10%-50% glycerol) cleaning.
(3)静置15min后,将芯片装入与芯片契合的适配框架结构中,把芯片上层粘膜,并且把整个蛋白芯片8真空密封处理并置于4℃备用。(3) After standing for 15 minutes, put the chip into the adapter frame structure that fits with the chip, put the mucosa on the chip, and vacuum seal the
一种用于定量检测多种细胞因子的试剂盒,包括上述以白介素6为例的蛋白芯片8、适配器、细胞因子标准品以及荧光染料标记的检测抗体。A kit for quantitatively detecting a variety of cytokines, comprising the above-mentioned
参照图1-4,适配器包括软乳胶片3、内框2和外框1。外框1开设有多个供内框2插接的安装孔4,且外框1下端的内周凸设有定位环5,内框2的下端凸设有阶梯台6。当内框2插接于安装孔4内,阶梯台6与定位环5卡接。1-4 , the adapter includes a
软乳胶片3插接于内框2内,且于阶梯台6的上端面抵接。软乳胶片3下端的外周开设有多个斜坡状的定位块7,蛋白芯片8卡接于定位块7和阶梯台6之间。The
安装时,先将内框2插接于外框1,再将蛋白芯片8置于通过两侧坡式的软乳胶片3将蛋白芯片8紧扣在外框1上,形成孔间互不交叉污染的矩阵抗体芯片。When installing, first insert the
参照图3,另外,组合塑料硬框与蛋白芯片8上并有对齐线和样品标号区9;外框1的每个安装孔4的尺寸大小与不同孔板适配,或可定制与微流控芯片大小适配的适配器。Referring to Fig. 3, in addition, there are alignment lines and sample labeling areas 9 on the combined plastic hard frame and the
参照图5,适配器可用于细胞实验,仅需在安装时将蛋白芯片8的抗体包被面置于内框2的底部,再把整个结构倒置于孔板中或与inserts联用即可。此外,蛋白芯片8也可直接用于细胞实验,放入其中。Referring to Figure 5, the adapter can be used for cell experiments. It is only necessary to place the antibody-coated surface of the
实施例2:定量检测白介素6的灵敏度及其在实际样品中使用与ELISA检测结果的比较Example 2: Sensitivity of quantitative detection of interleukin-6 and its use in actual samples compared with ELISA test results
利用本试剂盒进行白介素6定量检测的方法如下:The method for quantitative detection of interleukin-6 using this kit is as follows:
(1)IL-6标准品为自近岸蛋白质科技有限公司,货号C009,将标准品用PBS缓冲液(含有10%的甘油)倍比稀释为30,60,90,120,150,180pg/ml,同时设置阴性对照为PBS缓冲液(含有10%的甘油)。实际上,在其他实施例中,用于做标准曲线的重组蛋白浓度可以选用不同的区间,并不局限于此浓度。(1) The IL-6 standard is from Nearshore Protein Technology Co., Ltd., product number C009. The standard is diluted with PBS buffer (containing 10% glycerol) to 30, 60, 90, 120, 150, 180 pg/ml, and set negative at the same time The control was PBS buffer (containing 10% glycerol). In fact, in other embodiments, the recombinant protein concentration used for the standard curve can be selected from different ranges, and is not limited to this concentration.
(2)将稀释好的8个IL-6标准品分别加入实施例1中2x 8蛋白芯片8中的上面八个芯片中,并写好编号。(2) Add the diluted 8 IL-6 standard products to the upper eight chips in the 2×8
(3)准备测试样品1-8并进行ELISA检测:96孔板中的细胞上清液样品1,96孔板中inserts上层和下层细胞培养液样品2和3,已知浓度的IL-6稀释液样品4-8的浓度分别为(4,20,80,150,200pg/ml),从样品1-8中各取100μl用于ELISA试剂盒检测。ELISA试剂盒为达科为生物技术有限公司的IL-6检测试剂盒,货号为1110602,具体操作步骤根据说明书进行操作。(3) Prepare test samples 1-8 and perform ELISA detection:
(4)分别将蛋白芯片8和带适配器的蛋白芯片8放置于样品1-3中孵育,不同样品放置方法见图5;样品4-8分别加入图3所示的不同芯片中孵育。(4) The
(5)芯片从样品中取出后用PBS缓冲液(含有10%的甘油+0.05%Tween 20)洗3次。(5) The chip was washed three times with PBS buffer (containing 10% glycerol + 0.05% Tween 20) after the chip was taken out from the sample.
(6)加入CY3标记的检测抗体孵育1h。(6) Add CY3-labeled detection antibody and incubate for 1 h.
(7)用PBS缓冲液(含有10%的甘油+0.05%Tween 20)洗3次后用Juli Stage进行扫描,专业软件进行分析计算。(7) After washing 3 times with PBS buffer (containing 10% glycerol + 0.05% Tween 20), scan with Juli Stage, and analyze and calculate with professional software.
结果:使用本申请试剂盒的标准曲线和检测结果以及ELISA检测,参照图6和图7,其中,Results: Using the standard curve and detection results of the kit of this application and ELISA detection, refer to Figure 6 and Figure 7, wherein,
(1)蛋白芯片的标准曲线线性好,R2>99%。(1) The standard curve of the protein chip has good linearity and R 2 >99%.
(2)其检测的8个样品中,实际样品1-3(96孔板细胞样品1,96孔板inserts上层和下层细胞样品2和3)的蛋白芯片检测结果和ELISA结果基本一致,证明该检测方法的准确度高,实际可行。(2) Among the 8 samples tested, the actual samples 1-3 (96-well
(3)已知浓度的IL-6稀释液样品4-8,浓度分别为(4,20,80,150,200pg/ml),其中样品5-8蛋白芯片检测的准确性和重复性均优于ELISA;此外,样品4用ELISA未检出,但蛋白芯片准确检测出了,证明蛋白芯片有更高的灵敏度。(3) The known concentration of IL-6 dilution samples 4-8, the concentrations are (4, 20, 80, 150, 200pg/ml), and the accuracy and repeatability of the protein chip detection of samples 5-8 are excellent In addition,
实施例3:定量检测多种细胞因子的灵敏度在实际样品中与ELISA检测结果的比较利用本试剂盒定量检测白介素6,白介素8,肿瘤坏死因子α和白介素1β,蛋白芯片制备方法同实施例1:Example 3: Comparison of Sensitivity for Quantitative Detection of Various Cytokines in Actual Samples and ELISA Test Results Using this kit to quantitatively detect
(1)将稀释好的8个不同浓度的IL-6,IL-8,TNF-α和IL-1β的标准品的混合物分别加入实施例1中2×8芯片中的上面八个芯片中,并写好编号。(1) Add the diluted standard mixtures of 8 different concentrations of IL-6, IL-8, TNF-α and IL-1β to the upper eight chips in the 2×8 chips in Example 1, respectively, and write the number.
(2)准备测试样品1-8:96孔板细胞样品1,96孔板inserts上层和下层细胞样品2和3,和已知浓度的细胞因子稀释液混合样品(IL-6,IL-8,TNF-α和IL-1β均已同样的浓度混合)4-8的浓度分别为(10,50,100,150,200pg/ml),从样品1-8中各取100μl用于ELISA试剂盒检测。ELISA试剂盒为达科为生物技术有限公司的检测试剂盒(1110802,1110602,1110122,1117202),具体操作步骤根据说明书进行操作。(2) Prepare test samples 1-8: 96-well
(4)分别向样品1-8中放置芯片并孵育1h或将芯片放于培养设备内规定时间。(4) Place chips in samples 1-8 respectively and incubate for 1 h or place the chips in the culture equipment for a specified time.
(5)芯片从样品中取出后用PBS缓冲液(含有10%的甘油+0.05%Tween 20)洗3次。(5) The chip was washed three times with PBS buffer (containing 10% glycerol + 0.05% Tween 20) after the chip was taken out from the sample.
(6)加入CY3标记的混合检测抗体孵育1h。(6) Add CY3-labeled mixed detection antibody and incubate for 1 h.
(7)用PBS缓冲液(含有10%的甘油+0.05%Tween 20)洗3次后用Juli Stage进行扫描,专业软件进行分析计算。(7) After washing 3 times with PBS buffer (containing 10% glycerol + 0.05% Tween 20), scan with Juli Stage, and analyze and calculate with professional software.
结果:使用本发明试剂盒的标准曲线和检测结果以及ELISA检测结果参照图8和表1,其中,Result: Refer to Figure 8 and Table 1 for the standard curve and detection results and ELISA detection results of the kit of the present invention, wherein,
(1)蛋白芯片的标准曲线R2>99%。(1) The standard curve R 2 of the protein chip was >99%.
(2)其检测的8个样品中,实际样品1-3(96孔板细胞样品1,96孔板inserts上层和下层细胞样品2和3)的蛋白芯片检测结果和ELISA结果基本一致。(2) Among the 8 samples tested, the actual samples 1-3 (96-well
(3)已知浓度的细胞因子稀释液样品4-8,浓度分别为(10,50,100,150,200pg/ml),三次结果的平均值见表1。(3) Cytokine dilution samples 4-8 with known concentrations, the concentrations are (10, 50, 100, 150, 200 pg/ml), respectively. The average value of the three results is shown in Table 1.
表1多种细胞因子的检测结果表Table 1 Detection results table of various cytokines
由表1可知蛋白芯片检测的浓度准确性相对高于ELISA;此外,样品4由于浓度过低用ELISA检出难度大,但蛋白芯片可检出,证明蛋白芯片灵敏度高;根据结果可知4个检测体系之间无交叉反应。It can be seen from Table 1 that the concentration accuracy of protein chip detection is relatively higher than that of ELISA; in addition,
以上均为本申请的较佳实施例,并非依此限制本申请的保护范围,故:凡依本申请的结构、形状、原理所做的等效变化,均应涵盖于本申请的保护范围之内。The above are all preferred embodiments of the present application, and are not intended to limit the protection scope of the present application. Therefore: all equivalent changes made according to the structure, shape and principle of the present application should be covered within the scope of the present application. Inside.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210817114.XA CN115060913A (en) | 2022-07-12 | 2022-07-12 | A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210817114.XA CN115060913A (en) | 2022-07-12 | 2022-07-12 | A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115060913A true CN115060913A (en) | 2022-09-16 |
Family
ID=83206826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210817114.XA Pending CN115060913A (en) | 2022-07-12 | 2022-07-12 | A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115060913A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608332A (en) * | 2012-03-22 | 2012-07-25 | 电子科技大学 | Enzyme-linked immunoassay (ELISA) method of grass carp interleukin 10 |
CN104111329A (en) * | 2013-04-17 | 2014-10-22 | 广州瑞博奥生物科技有限公司 | Improved antibody chip kit capable of quantitatively detecting multiple cell factors synchronously |
CN204162719U (en) * | 2014-10-17 | 2015-02-18 | 广州瑞博奥生物科技有限公司 | A kind of reaction unit for ankyrin chip or gene chip |
CN104655851A (en) * | 2013-11-22 | 2015-05-27 | 广州瑞博奥生物科技有限公司 | Antibody chip kit for simultaneous quantitative detection of multiple receptors |
-
2022
- 2022-07-12 CN CN202210817114.XA patent/CN115060913A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608332A (en) * | 2012-03-22 | 2012-07-25 | 电子科技大学 | Enzyme-linked immunoassay (ELISA) method of grass carp interleukin 10 |
CN104111329A (en) * | 2013-04-17 | 2014-10-22 | 广州瑞博奥生物科技有限公司 | Improved antibody chip kit capable of quantitatively detecting multiple cell factors synchronously |
CN104655851A (en) * | 2013-11-22 | 2015-05-27 | 广州瑞博奥生物科技有限公司 | Antibody chip kit for simultaneous quantitative detection of multiple receptors |
CN204162719U (en) * | 2014-10-17 | 2015-02-18 | 广州瑞博奥生物科技有限公司 | A kind of reaction unit for ankyrin chip or gene chip |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5939281A (en) | Detecting alloreactivity | |
AU2007325465B2 (en) | Assay membrane and method of use thereof | |
US6410252B1 (en) | Methods for measuring T cell cytokines | |
CN104111329B (en) | A kind of simultaneous quantitative of improvement detects the antibody chip kit of multiple cell factors | |
US20070054326A1 (en) | Antibody-based protein array system | |
CN101833001B (en) | Protein chip kit for detecting inflammatory factors and preparation method thereof | |
Knight et al. | Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis | |
US7598093B2 (en) | Nanoparticle and microparticle based detection of cellular products | |
US20090075828A1 (en) | Integrated protein chip assay | |
Li et al. | Adapting cDNA microarray format to cytokine detection protein arrays | |
WO2017107540A1 (en) | Antibody-array test kit for detecting proteins related to periodontal disease | |
CN1205479C (en) | Immunological diagnosis protein chip preparation method | |
CN115060913A (en) | A protein chip for quantitatively detecting multiple cytokines and its preparation method and kit | |
US6824986B1 (en) | Methods for measuring in vivo cytokine production | |
Sreekumar et al. | Using protein microarrays to study cancer | |
WO2007130549A1 (en) | Monoclonal antibody microarray | |
CN112698036A (en) | Immune test paper strip for rapidly determining cross reaction of bacterial monoclonal antibody and determination method | |
JP2006105803A (en) | Biological sample material analysis method, analyzer, microarray, and immunoassay | |
US6951716B2 (en) | Anti-platelet immunoglobulin bead positive control | |
CN113945713B (en) | Biochip for combined detection of multiple tumor markers and preparation and application thereof | |
CN104833782A (en) | Method for in-vitro screening and detection of anti-cow-endometritis medicaments | |
Kramer et al. | Protein microarrays | |
Xu et al. | Development and application of antibody microarray for white spot syndrome virus detection in shrimp | |
JP2007147494A (en) | Simultaneous substance measuring method, and support for measurement used in for same | |
Geierstanger et al. | Antibody microarrays using resonance light-scattering particles for detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |